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Prognostic factorsAbstract Background: Pediatric diffuse intrinsic pontine glioma (DIPG) remains dismal regard-
less the new therapeutic and technical advances.
Objective: To investigate the value of magnetic resonance imaging (MRI) in predicting DIPG
prognosis.
Patients and methods: Twenty-ﬁve DIPG patients with 95 (initial and post radiotherapy) MR
examinations were studied. Hydrocephalus was detected in 6 cases (24%), basilar artery encasement
in 20 (80%), ill deﬁned border in 16 (64%), perilesional edema in 2 cases (8%) and none showed
leptomeningeal spread. Conformal 3-dimensional radiotherapy (39 Gy/13 fractions or 54 Gy/30
fractions) was applied.
Results: The median overall survival (MOS) was 9.3 months (95% CI: 7.9–10.8) and the one year
overall survival was 18 ± 8.9%. Post radiation MRI performed 3–6 months after treatment showed
regression in 8 cases (32%), stationary course in 5 (20%) and progression in 12 cases (48%). The
MOS was higher in children whose MRI showed regression (10.0, CI: 6.3–13.7) than those with
872 A.M. Aly et al.radiological progression (8.0, CI: 5.9–10.1 months) or stationary course (7.0, CI: 4.9–9.1). However;
these differences did not rank to the level of signiﬁcance. There was no statistical association of
tumor size (p= 0.907), presence of hemorrhage (p= 0.314), or surrounding edema (p= 0.263);
entrapment of the basilar artery (p= 0.782); pattern of enhancement (p= 0.851); and hydroceph-
alus (p= 0.354) with the length of the overall survival.
Conclusions: Though MRI is the mainstay for the diagnosis of DIPG, yet its prognostic value is
limited. New MR techniques as MR spectroscopy and diffusion tensor imaging should be evaluated
as additional tools for prognostic evaluation of DIPG.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Diffuse intrinsic pontine glioma remains one of the most chal-
lenging solid tumors to be treated in children. The incidence of
these tumors is rare, with an estimated 300 children newly
diagnosed in the United States each year with a peak incidence
between 5 and 9 years (1,2). The majority of these tumors
arises in the pons and usually present with short duration of
signs and symptoms but with signiﬁcant neurologic impair-
ment. Essentially; brain stem gliomas are divided into two
main categories; 20% being low grade, arising in the midbrain,
medulla or dorsal pons, often focal and dorsally exophytic,
amenable to surgical resection and with a relatively good prog-
nosis. The remaining 80% of the tumors arise and occupy the
majority of the pons and are diffuse in nature with a dismal
prognosis. This latter group termed DIPG remains one of
the most challenging pediatric tumors.
Radiation therapy is the standard treatment, providing
transient palliation of the neurological symptoms in 75–85%
of patients. Conventional radiotherapy for brain stem glioma
has been associated with an overall median survival of 8–
11 months. Despite advances in radiation therapy techniques,
primary tumor progression remains the major cause of death
in patients with DIPG (3,4).
The typical MRI ﬁndings in DIPG are intrinsic, pontine
based inﬁltrative lesion; hypointense in T1 weighted images
(T1WIs) and hyperintense in T2 sequences, with a signiﬁcant
mass effect on the adjacent structures. These ﬁndings are diag-
nostic, making histological conﬁrmation unnecessary (5).
AlthoughMR images have been shown to be able to demon-
strate the response to therapy in DIPG (6,7), still there is a de-
bate about the ability of MRI to predict survival in children
suffering from these tumors. The aim of this retrospective study
is to try to reveal this debate through radiological reviewing of a
series of children with DIPG treated at our institute.
2. Patients and methods
After obtaining the approval of our hospital’s institutional re-
view board (IRB), the study was activated. The computerized
oncology records of 25 pediatric patients with DIPG treated in
our hospital over 4 years period between July, 2007 and June,
2011 have been reviewed. Ninety-ﬁve MRI studies of these pa-
tients have been reviewed which were performed upon diagno-
sis, after completion of radiotherapy course and during follow
up. These 25 patients were selected from a total of 59 DIPG
patients treated during this period. Thirty-four patients were
excluded from the study as they never performed a MRI exam-
ination after completion of treatment.For inclusion in this study the lesion has to be pontine in
origin which means that the center of the lesion has to be in
the pons and involves >50% of its axial area.
MRI studies were performed using Siemens Magnetom
Espree 1.5T MRI System with a standard head coil. Prior to
contrast injection; axial FLAIR, axial T2 WIs, axial T1 WIs,
sagittal T2 WIs and coronal T1 sequences were obtained. After
contrast injection (gadopentate dimeglumine 0.2 mmol/kg);
axial, sagittal and coronal T1WIs were acquired. Patients be-
low the age of 5 years (7/25 = 28%) were sedated with sevoﬂu-
rane using MRI compatible anesthesia machine.
The images were reviewed on PACS workstation. The radi-
ologists were blinded to the identity and clinical status of the
patients. All measurements were made on the three planes; ax-
ial, sagittal and coronal sequences.
Each MRI examination was analyzed for the following: tu-
mor site, size, volume, extension, border (well deﬁned or ill de-
ﬁned), signal intensity, pattern of enhancement; presence of
hemorrhage, necrosis, surrounding edema; exophytic growth;
entrapment of the basilar artery; leptomeningeal spread and
hydrocephalus.
Exophytic growth was deﬁned as extension of the tumor
into the adjacent cistern or ventricle. The basilar artery was
considered entrapped when more than 180 of its perimeter
was encircled by the tumor.
The maximum anteroposterior diameter (d1) of the tumor
was measured in axial and sagittal planes; the maximum trans-
verse diameter (d2) was measured in axial and coronal planes
while the maximum craniocaudal diameter (d3) was measured
in the sagittal and coronal planes. The tumor volume was cal-
culated as d1 · d2 · d3 · 0.54.
If multiple discrete lesions were present, only the largest one
was measured while the other smaller lesions were analyzed
regarding their signal intensity andpatternof enhancement only.
A progressive course was considered when there was an
increase in the volume of the tumor >25% of its original
volume while a regressive course was considered when there
was a decrease in the volume of the tumor >25% of the origi-
nal volume. When the change in the tumor volume was <25%
either by increase or decrease, this was considered a stationary
course.
Newly developed lesions, increased enhancement of the tu-
mor, more involvement of brain stem segments, hydrocephalus
and leptomeningeal spread were considered as other features
of progression while decreased enhancement of the tumor with
increased or newly developed areas of breaking down were
considered features of regression.
Each scan was compared to the previous one taking into
consideration all the previously mentioned points.
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ologists (A.M.A and A.R.); disagreement was resolved by joint
reevaluation.
The medical charts were reviewed for gender, age, symp-
toms at diagnosis, lag from appearance of symptoms to diag-
nosis, clinical examinations on follow up and the length of
follow up. The parameters recorded from the clinical evalua-
tion were cranial nerve palsy, paresis, ataxia and level of con-
sciousness. The clinical ﬁndings were graded as stable,
improved or worsened and were compared to the grading from
the nearest MRI scan. New onset of cranial nerve palsy, pare-
sis, ataxia, involvement of additional nerves, or motor impair-
ment of additional limbs and decrease in the level of
consciousness were considered clinical worsening. Reversal of
this pattern was deﬁned as improvement. The interval between
the clinical and the imaging evaluation was recorded.
2.1. Statistical analysis
The overall survival rates were calculated using the
Kaplan–Meier product-limit method. All possible clinical
and radiological parameters that could affect the overall sur-
vival were analyzed using the Log Rank test.
3. Results
The study group consists of 25 patients (95 MRI examina-
tions), 16 boys and 9 girls aged 3–16 years (median 9 years).
The patients’ characteristics are shown in Table 1. The patients
presented prior to radiotherapy with at least two of the follow-
ing symptoms; cranial nerve palsy (88%), ataxia (48%) or long
tract deﬁcits (64%). All patients had a duration of these symp-
toms of 3 months or less with a median of one month.
All patients received radiation therapy as a primary treat-
ment. Eleven of the 25 patients received the prescribed dose
of 3900 cGy in 13 fractions of 300 cGY and 14 patients re-
ceived the prescribed dose of 5400 cGy in 30 fractions of
180 cGy. The clinical target volume (CTV) included the tumor
as deﬁned by the MR T2WIs with a margin of 1.5 cm. These
margins were adjusted for bony structures and tentorium. An-
other margin of 0.5 cm is added to create the planning target
volume (PTV) to compensate for systematic and random er-
rors according to the department policy. No neoadjuvant, con-Table 1 Patient characteristics.
Characteristic Results
Total 25
Gender 16 Boys and 9 girls
Age at diagnosis 3–16 Years (median 9 years)
Duration of presenting
symptom
Median 1 (range 1–3) month
Presenting symptoms Cranial nerve palsy (84%)
Ataxia (40%)
Long tract deﬁcits (60%)
Radiotherapy
treatment
Conventional fractionation 14 patients
Hypo fractionation 11 patients
Survival The median overall survival was 9.3 months
(95% CI: 7.9–10.8) one-year overall
survival was 22.9 ± 8.9%comitant or adjuvant systemic treatments were given apart
from steroids.
The imaging ﬁndings at the initial diagnosis are summa-
rized in Table 2. Eighteen cases were located in the pons,
one case in the pons and left cerebellum, three cases in the pons
and medulla, two cases in the pons and midbrain and one case
in the pons, medulla and left cerebellar hemisphere.
All cases have diffuse lesions and six of them had exophytic
component in addition.
Upon presentation; 23 cases (92%) showed T2 and FLAIR
WIs high signal intensity while two cases (8%) were isointense
to the surrounding brain stem parenchyma. On T1WIs; ﬁfteen
cases (60%) were hypointense; four cases (16%) were isointense
to the brain stem parenchyma and six cases contained hemor-
rhagic elements seen as high signal intensity. After contrast
injection, eleven cases (44%) did not show enhancement while
fourteen (56%) cases show different patterns of enhancement.
Hydrocephalus was present in six cases (24%); basilar ar-
tery encasement was seen in twenty cases (80%), nine cases
had well deﬁned tumor border (36%) while sixteen cases had
ill deﬁned borders (64%), necrosis was seen in eight cases
(32%) and two cases (8%) showed peritumoral edema.
None of the patients showed any leptomeningeal spread at
the time of diagnosis but two cases developed leptomeningeal
spread as a sign of progression.
On follow up, comparison of MRI 3–6 months post radio-
therapy to the initial one showed radiologically progressive
course of the disease in twelve cases. This progression pre-
sented by different radiological patterns is shown in Table 3.
Radiological regression of the disease was seen in eight
cases and presented in Table 4.
The condition was radiologically stationary in ﬁve cases.
On follow up, progression of the disease was clinically evi-
dent in 15 cases but only 9 of them were conﬁrmed radiologi-
cally. The disease was stable clinically and radiologically in 4
cases, stable clinically but showed regression in MRI in an-
other 3, while clinically stable in 1 patient but showed progres-
sion in MRI. The disease was improved clinically in 2 cases but
showed progression by MRI (Table 5).
Figs. 1 and 2 show the dissociation between the radiological
features of the tumor post radiation and the clinical condition of
the patient.
The median overall survival (MOS) for the 25 children was
9.3 months (95% CI: 7.9–10.8) and the one year overall sur-
vival rate was 18 ± 8.9% (Fig. 3).
There was no statistical association of tumor size
(p= 0.907), presence of hemorrhage (p= 0.314), or surround-
ing edema (p= 0.263); entrapment of the basilar artery
(p= 0.782); pattern of enhancement (p= 0.851); and hydro-
cephalus (p= 0.354) with the length of the overall survival.
MRI-regression children had MOS of 10.0 months (CI:
6.3–13.7) that was higher than those showing MRI progression
(8.0, CI: 5.9–10.1 months) or stationary condition (7.0, CI:
4.9–9.1). However; these differences did not rank to the level
of signiﬁcance (p= 0.096) (Fig. 4).
4. Discussion
Diffuse intrinsic pontine gliomas typically involve more than
one half of the affected brain stem segment. However; they
may inﬁltrate brain stem segments cranial or caudal to the ori-
gin (8).
Table 2 Baseline MRI ﬁndings at ﬁrst presentation of the
patients.
MRI ﬁnding Number
Site
Pons 18
Pons and left cerebellum 1
Pons and medulla 3
Pons and midbrain 2
Pons, medulla and left cerebellum 1
Type
Diﬀuse without exophytic component 19
Diﬀuse with exophytic component 6
Signal intensity
T1WIs
Low signal 15
Isointense signal 4
High signal of intra-tumoral hemorrhage 6
T2WIs
High signal 23
Isointense signal 2
Contrast enhanced images
No enhancement 11
Diﬀerent patterns of enhancement 14
Hydrocephalus 6
Basilar artery encasement 20
Border of the tumor
Well deﬁned 9
Ill deﬁned 16
Necrosis 8
Peritumoral edema 2
Leptomeningeal spread 0
874 A.M. Aly et al.Diffuse gliomas comprise around 90% of brain stem tumors
in children with peak incidence between 5 and 10 years (9).
The classic clinical triad at presentation consists of ataxia,
long tract signs and cranial nerve deﬁcits. Cranial nerves VI
and VII are typically involved as these tumors are mainly lo-
cated in the pons (10).
In the present study, patients presented with at least two of
these symptoms; cranial nerve palsy (88%), ataxia (48%) or
long tract deﬁcits (64%). All patients had a duration of these
symptoms of a median of one month.
In the last 20 years, pediatric neuro-oncology has beneﬁted
from a number of advances. New neuroradiological tools have
become available, such as MR spectroscopy, MR diffusion,Table 3 MRI features of progression in twelve cases.
MRI features
Increased size of the lesion
Involvement of additional segments of the brain stem
Increased enhancement of the lesion
Newly developed enhancing nodules
Increased size of the lesion plus newly developed hydrocephalus
Increased size of the lesion plus increase in enhancement of the lesion wit
newly developed enhancing lesion in the left parietal lobe
Increase in size of the lesion with newly developed hydrocephalus and
leptomeningeal spread
Increase in size of the lesion with newly developed leptomeningeal spreadMRdiffusion tensor and PET, with their speciﬁc diagnostic po-
tential. Radiotherapeutic techniques have improved as well, en-
abling the doses delivered to the tumor to be increased without
further harming the healthy brain. In the majority of cases, the
diagnosis of DIPG and the treatment decision are based solely
on MR imaging without biopsy, because of fear of associated
complications. However, data from previous MR studies re-
vealed that diffuse pontine tumors have worse prognosis than
dorsally exophytic, focal and midbrain centered tumors (3).
Studies correlating the clinical presentation and the tumor
characteristics with outcome are scarce. The identiﬁcation of
imaging signs that could help clinicians predict response to
therapy and length of survival would be highly contributory
to the management of these patients (11).
Our study analyzed a pure population of DIPG, with the
lesion centered in the pons and involves more than 50% of
the axial area. From this group we were unable to ﬁnd any pre-
dictive prognostic factor that correlated with the survival. Tu-
mor size, presence of hemorrhage, surrounding edema;
entrapment of the basilar artery; pattern of enhancement and
hydrocephalus did not predict the subsequent course of the
disease. This ﬁnding is contradictory to what has been
achieved by Fisher et al., Kaplan et al. and Smith et al. (12–
14) as their studies included exophytic, focal and midbrain cen-
tered tumors. Furthermore, their studies suggested that dura-
tion of symptoms, gadolinium enhancement and basilar
artery encasement all had prognostic signiﬁcance. These clini-
cal and MRI variables differentiate DIPG from other less
aggressive brain stem gliomas.
However, our ﬁndings were nearly comparable to Kornr-
eich et al. (7), as they did not ﬁnd any association between
the imaging ﬁndings at diagnosis and the length of survival.
The single prognostic sign in their study was the presence of
hydrocephalus at diagnosis, which was associated with a short-
er progression-free survival (P= 0.02), probably due to rapid
tumor growth (15).
The median overall survival for our patients was
9.3 months which is nearly comparable with other reports with
a median overall survival ranges from 8 to 11 months (16–18).
Two studies (19–20) had longer median overall survival than
our study of 15 months and 16 months respectively; they did
not provide information on clinicoradiological eligibility and
included some patients with duration of symptoms of up to
12 months. Furthermore, only 50% (8/16) of Wakabayashi
et al. (20) were diagnosed as DIPG; the remaining 50% were
pure focal or exophytic brainstem gliomas.Number
3
1
1
2
2
h 1
1
1
Table 4 MRI features of regression in eight cases.
MRI features Number
Decrease in size of the lesion 3
Decrease in size of the lesion plus complete regression of enhancement 1
Deceased enhancement of the lesion plus increased areas of breaking down 2
Decrease in size of the lesion with complete disappearance of the hydrocephalus 1
Decreased areas of enhancement plus decrease in the hemorrhagic component with newly developed areas of breaking down 1
Table 5 Clinical and radiological correlation of the patient’s
response.
MRI
regression
MRI
stable
MRI
progression
Clinical regression – – 2
Clinical stable 3 4 1
Clinical progression 5 1 9
Total 8 5 12
Can conventional magnetic resonance imaging predict survival in pediatric diffuse intrinsic pontine glioma? 875Local relapse has been extensively documented in many ser-
ies as the primary mode of failure in DIPG (21–23), that is why
we did not undergo in our study routine neuraxis imaging after
initial therapy and spinal imaging were reserved forFig. 1 Axial T2-weighted image (a) shows high signal intensity dif
obstruction of the fourth ventricle (white arrow) and basilar artery e
components. The sagittal post contrast T1-weighted image (b) shows
arrow). (c) Post radiotherapy shows marked decrease in size of the lesio
arrow) and complete regression of the basilar artery encasement by the
image (d) shows marked decrease in size of the lesion with almost com
showed signiﬁcant radiological regression, the patient was clinically stsymptomatic patients. However; study done by Sethi et al.
(24) recommended that all DIPG patients undergo spine and
brain MRI scans at the time of initial presentation and at
regular intervals during follow up as high incidence of
leptomeningeal disease was observed at diagnosis and recur-
rence. In their study, patients with leptomeningeal involvement
had shorter overall survival compared to patients with local-
ized disease. Some form of CNS prophylaxis should be consid-
ered in future clinical trials (24).
In a study done by Ibrahim et al. (25), diffusion tensor
imaging provided information which further deﬁned precise
relations between the sub cortical white matter structures
and the brain tumors which potentially has a role in tumor
characterization and preoperative planning (25).fuse pontine lesion (black arrow) with displacement and partial
ngulfment (black arrowhead). The lesion shows solid and cystic
strong enhancement of the solid component of the lesion (white
n with restoration of the normal size of the fourth ventricle (black
tumor (white arrowhead). The sagittal T1-weighted post contrast
plete disappearance of the tumor enhancement. Although this case
able.
Fig. 2 Axial Flair-weighted image (a) shows high signal intensity diffuse pontine lesion (black arrow). The lesion shows high signal
intensity in the sagittal T1-weighted image (b) denoting hemorrhagic component. (c) Post radiotherapy shows almost complete loss of the
high signal intensity of the tumor with newly developed low signal intensity inside the lesion (white arrow) denoting necrosis. The sagittal
T1-weighted image (d) shows almost complete disappearance of the hemorrhagic component of the tumor. This case showed clinical
progression in spite of the radiological regression.
Fig. 3 Median overall survival in the 25 patients.
876 A.M. Aly et al.
Fig. 4 Median overall survival in patients with MRI progression, regression and stationary.
Can conventional magnetic resonance imaging predict survival in pediatric diffuse intrinsic pontine glioma? 8775. Conclusion
Magnetic Resonance Imaging is still the mainstay for the diag-
nosis and follow up of diffuse intrinsic pontine glioma. How-
ever, the prognostic value of this imaging modality is limited.
New magnetic resonance techniques such as MR spectroscopy
and diffusion tensor imaging should be evaluated as additional
tools for the management of these tumors.
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